These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1720417)

  • 1. The immunosuppressive agent FK506 inhibits in vitro expression of membrane-bound and soluble interleukin-2 receptors on resting but not on activated human lymphocytes.
    Karlsson H; Truedsson L; Nässberger L
    Immunol Lett; 1991 Sep; 30(1):129-32. PubMed ID: 1720417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506.
    Foxwell BM; Willcocks JL; Taylor-Fishwick DA; Kulig K; Ryffel B; Londei M
    Eur J Immunol; 1993 Jan; 23(1):85-9. PubMed ID: 7678231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.
    Schleuning M; Brumme V; Wilmanns W
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):100-3. PubMed ID: 7523957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.
    Keicho N; Kudoh S; Yotsumoto H; Akagawa KS
    J Antibiot (Tokyo); 1993 Sep; 46(9):1406-13. PubMed ID: 7693639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolic inhibition of the human lymphocyte: influence on the expression of interleukin-2 receptors.
    Karlsson H; Nässberger L
    Immunol Cell Biol; 1992 Oct; 70 ( Pt 5)():309-13. PubMed ID: 1478696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
    Härtel C; Schumacher N; Fricke L; Ebel B; Kirchner H; Müller-Steinhardt M
    Clin Chem; 2004 Jan; 50(1):141-51. PubMed ID: 14709642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
    Pockley AG; Williams S; Reid SD; Bowles MJ
    Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
    J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Oka T
    Transplantation; 1989 Feb; 47(2):351-6. PubMed ID: 2465592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
    Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of experimental crescentic-type anti-glomerular basement membrane (GBM) nephritis by FK506 (tacrolimus hydrate) in rats.
    Hayashi K; Nagamatsu T; Ito M; Suzuki Y
    Jpn J Pharmacol; 1996 Jan; 70(1):43-54. PubMed ID: 8822088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta.
    Szamel M; Bartels F; Resch K
    Eur J Immunol; 1993 Dec; 23(12):3072-81. PubMed ID: 8258320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
    Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML
    Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506 lacks the ability to inhibit expression of interleukin-2 receptor beta-chain on human lymphocytes.
    Karlsson H; Nässberger L
    J Clin Lab Immunol; 1991 Sep; 36(1):45-7. PubMed ID: 1726895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 enhances IL-13 production by T cells activated through CD3/CD28.
    Dumont FJ
    Int Arch Allergy Immunol; 1997 Nov; 114(3):300-1. PubMed ID: 9363914
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.
    Thomson AW; Bonham CA; Zeevi A
    Ther Drug Monit; 1995 Dec; 17(6):584-91. PubMed ID: 8588225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
    Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
    Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.